John Kelley
Interventional Cardiology · Raleigh, NCNPI 1750380705
Payments from drug & device makers
Across 107 payments — averaging $67.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Siemens Medical Solutions USA, Inc.$4K
- Corindus Inc.$427
- Abiomed$413
- Boston Scientific$366
- Teleflex LLC$274
- Shockwave Medical, Inc$230
- plus $1K from 21 others
What the payments were for
- Consulting fees$1,50021%
- Speaking & faculty fees$75010%
- Travel & lodging$72710%
- Food & beverage$4,25059%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 27 | $4,252 |
| Corindus Inc. | 1 | $427 |
| Abiomed | 5 | $413 |
| Boston Scientific | 4 | $366 |
| Teleflex LLC | 4 | $274 |
| Shockwave Medical, Inc | 3 | $230 |
| AstraZeneca | 6 | $204 |
| Novartis | 7 | $117 |
| Angiodynamics, Inc. | 1 | $117 |
| Johnson & Johnson | 8 | $108 |
| Cardiovascular Systems Inc. | 5 | $102 |
| Philips North America LLC | 5 | $93 |
| Scpharmaceuticals Inc. | 1 | $64 |
| E.r. Squibb & Sons, L.L.C. | 5 | $59 |
| Sanofi-aventis U.S. LLC | 3 | $57 |
| Pfizer | 4 | $53 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $48 |
| Nuwellis, Inc. | 3 | $48 |
| Amgen | 3 | $46 |
| Kowa Pharmaceuticals America, Inc. | 2 | $26 |
| Bristol Myers Squibb | 1 | $22 |
| Bard Access Systems, Inc. | 1 | $22 |
| Merck | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Smith+Nephew | 1 | $17 |
| Irhythm Technologies, Inc. | 1 | $15 |
| Kestra Medical Technology Services, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CorPath Imaging System$2,151
- CorPath GRX$1,812
- Impella$389
- TURNPIKE$215
- OPTICROSS$167
- Rotablator Rotational Atherectomy System Console Kit$150
- Vascular Lithotripsy$142
- FARXIGA$121
How this compares
$7,232 in reported general payments places this provider in the 45th percentile of 180 interventional cardiology providers in North Carolina.
See all interventional cardiology providers in North Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 75 | $73,754 |
| XareltoRivaroxaban | 17 | $17,928 |
| EntrestoSacubitril/Valsartan | 11 | $12,631 |
| Ranolazine ErRanolazine | 16 | $985 |
| Metoprolol Succinate | 53 | $760 |
| ClopidogrelClopidogrel Bisulfate | 36 | $445 |
| Metoprolol Tartrate | 51 | $327 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 15 | $296 |
| Atorvastatin Calcium | 27 | $287 |
| Rosuvastatin Calcium | 17 | $267 |
| Digoxin | 11 | $219 |
| Carvedilol | 23 | $186 |
| Losartan Potassium | 33 | $152 |
| Spironolactone | 19 | $136 |
| Amlodipine Besylate | 39 | $130 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $53 | $73,75475 claims |
| Johnson & JohnsonXarelto | $108 | $17,92817 claims |
| NovartisEntresto | $117 | $12,63111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 180 interventional cardiology providers in North Carolina.
Other interventional cardiology in Raleigh
- Ravish SacharRaleigh$10.1M
- James ZidarRaleigh$1.1M
- Willis WuRaleigh$671K
- Robert JobeRaleigh$490K
- Dwijesh PatelRaleigh$445K
- Joel SchneiderRaleigh$361K
- Mohit PasiRaleigh$117K
- Deepak PasiRaleigh$115K
- Andrew SampsonRaleigh$95K
- Islam OthmanRaleigh$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.